The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: April 2026

April 28, 2026
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.


5. AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration

  • 1. The local microenvironment suppresses the synergy between irradiation and anti-PD1 therapy in breast-to-brain metastasis
  • 2. Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread
  • 3. A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survival
  • 4. Humoral determinants of checkpoint immunotherapy
  • 5. AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration
  • 6. NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity
  • 7. Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer
  • 8. Respiratory viral infections awaken metastatic breast cancer cells in lungs
  • 9. DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth
Previous
Next
Wu, X., Huang S., Gao, J. et al. Science Advances. 11(34): eadv6937. (2025).
doi: 10.1126/sciadv.adv6937.
Summary by Jukka Westermarck, EACR Board Member

Summary of the findings

The authors discover a very sophisticated mechanism how cancer cell metabolism links to posttranslational protein modification (PTMs) by nitration and thereby inhibits MYC expression and cancer cell invasion. In detail, aldo-keto reductase AKR1B10, known to be downregulated in cancer, unrelated to its metabolic functions, nitrates a regulatory subunit of protein phosphatase 2A which leads to increased PP2A holoenzyme assembly and MYC inhibition. In cancer cells in which AKR1B10 is lost, pharmacological PP2A activation restores MYC suppression and effectively mitigates metastasis.
.
This paper is a fascinating example how yet very poorly understood PTM, such as single amino acid nitration, can have pivotal role in cancer by mechanisms that are completely hidden by genetics studies, but dependent on regulation of protein interaction and chains of PTMs such as here nitration leading to dephosphorylation and MYC inactivation.
.
Read more in Nature Science Advances

5. AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration

  • 1. The local microenvironment suppresses the synergy between irradiation and anti-PD1 therapy in breast-to-brain metastasis
  • 2. Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread
  • 3. A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survival
  • 4. Humoral determinants of checkpoint immunotherapy
  • 5. AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration
  • 6. NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity
  • 7. Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer
  • 8. Respiratory viral infections awaken metastatic breast cancer cells in lungs
  • 9. DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

“An exchange that has had a lasting impact on my research, my laboratory and my development as a cancer researcher”:  Peijin Jiang’s Travel Fellowship

“An exchange that has had a lasting impact on my research, my laboratory and my development as a cancer researcher”: Peijin Jiang’s Travel Fellowship

September 23, 2026

Peijin Jiang is a PhD student at the Vall d’Hebrón Institute of Oncology (VHIO), Spain, who received an EACR Travel Fellowship to visit and work at...

“Practical insights into leadership, communication, negotiation, and career development”: Inside the 2026 Women in Leadership Workshop

“Practical insights into leadership, communication, negotiation, and career development”: Inside the 2026 Women in Leadership Workshop

September 11, 2026

" provided practical insights into leadership, communication, negotiation, and career development that directly align with the challenges of establishing and leading an independent multidisciplinary research program....

Virtual conferences are no longer a compromise: What six years of data reveals

Virtual conferences are no longer a compromise: What six years of data reveals

October 6, 2026

When the EACR ran its first virtual conferences in 2020, it was a decision made to address the quickly evolving Covid-19 crisis. International travel was near...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

VIDEO | Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution
News

VIDEO | Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution

October 8, 2026
VIDEO | The Evolving ADC Landscape: From Monotherapies to Rational Combinations and Next-Generation Platforms
News

VIDEO | The Evolving ADC Landscape: From Monotherapies to Rational Combinations and Next-Generation Platforms

October 1, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR